Views & Analysis Sitting uncomfortably? The UK’s PPRS and statutory schemes Do the PPRS and the statutory scheme run effectively in parallel?
Views & Analysis New business models turn science into market value Delivering better patient benefit and economic returns.
Views & Analysis The biggest pharma stories of 2016 so far The top 10 pharma milestones of the year to date.
Articles Information management needs proper governance Strike the right balance in data governance and reflect its importance through well-trained data stewards.
Views & Analysis After 2015's ‘breakthrough’ year for pharma approvals, will ... Roche's MS drug is among major drugs still to come in 2016.
Views & Analysis Trends in clinical research in China A large patient pool plus growing market opportunities are making China increasingly attractive for clinical trials.
News FDA orders blindness risk warning to GLP-1 agonist labels FDA has ordered all GLP-1 receptor agonist manufacturers to add a warning to their product labels for a rare eye condition that can cause blindness.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
